Press release
Biomarkers Summit
SMi's 4th annual Biomarkers summit featuring 28 leading industry experts, provides the perfect platform to network with other industry professionals, whilst gaining invaluable up to date knowledge from leaders in the Biomarker field.On Wednesday February 2nd, we will also be hosting an interactive post-conference workshop entitled:
Fit for Purpose Biomarkers: From Bench to Bedside
Hosted by: Eric Culbert, Executive Consultant, BioScience Innovations.
In association with: BioScience Innovations
This highly interactive workshop will highlight the nature and requirements of the different classes of biomarkers, the technologies most suited to developing biomarkers, and discuss case studies of biomarker development and implementation which will help illuminate the key issues which can arrive during the journey from bench to bedside.
To keep up to date with this event and workshop visit:
www.smi-online.co.uk/preclinical-biomarkers.asp
Program Overview – Topics & Speakers
Biomarkers In Oncology
Peter Smith, Senior Scientist II, Oncology, Millennium Pharmaceuticals
Robert Wilkinson, Principal Scientist II, AstraZeneca
Metodi Metodiev, Director of Proteomics Unit, University of Essex
Mathias Dreger, Head of Biochemistry, Caprotec
Huseyin Mehmet, Director of Exploratory Biomarkers, Diabetes, Merck
Fernando Ulloa-Montoya, Head of Molecular Biology Technology Group, GlaxoSmithKline Biologicals
Hans Winkler, Senior Director and Global Head, Oncology Biomarkers, Johnson & Johnson
Karen Asin, Director, Translational Pharmacology, Takeda
Patrick Murray, Professor of Clinical Pharmacology, University College Dublin (UCD)
Biomarkers in Immunology & CNS
Andrew Payne, Senior Group Leader, Cellular Sciences, UCB
Mark Fidock, Associate Research Fellow, Head of Quantitative Biomarkers, Pfizer
Matthew Albert, Director of Immunology, Institut Pasteur
Iain Kilty, Director Allergy and Respiratory Research Unit, Pfizer
Sabine Küsters, Director of Scientific Relations, Rules Based Medicine
Thomas Joos, Head of Biochemistry, Natural and Medical Sciences Institute (NMI)
Mette Jensen, Translational Medicine Scientist, Lundbeck
Jennifer Larsen, Translational Medicine Scientist, Lundbeck
Jens Mikkelsen, Professor, Neurosearch A/S
Biostatistics
Ziad Taib, Statistical Science Director, Astrazeneca
Ann Hastings, Translational Scientist, Astellas
Hugh Salter, Principal Scientist, Astrazeneca
Andreas Schuppert, Director, Bayer Technology Services / RWTH Aachen University
Personalised Medicine
Louise Leong, Head of R&D, Association of the British Pharmaceutical Industry (APBI)
Hayley Whitaker, Research Associate, Biomarkers, Cancer Research UK / University Of Cambridge
Ge Ruigt, Director Experimental Medicine Neuroscience, Merck
Shawnmarie Mayrand-Chung, Program Director, Biomarkers Consortium, National Institutes of Health (NIH)
Jean-Luc Sanne, Scientific Officer, European Commission's Research Directorate General
SPONSORSHIP & EXHIBITION INFORMATION
SMi Group offer excellent opportunities to profile your company through tailored sponsorship and branding packages.
Alia Malick tel: +44 (0) 20 7827 6168 email: amalick@smi-online.co.uk
TO BOOK
DELEGATE BOOKINGS
Zain Philbey tel: +44 (0) 20 7827 6722 email: zphilbey@smi-online.co.uk
Please visit www.smi-online.co.uk/preclinical-biomarkers.asp
Supported by: b3c Newswire, Bentham Science, Biocompare, Biomarkers in Medicine, BioMEV, BioNMD, Biotechniques, Business Monitor International, Canbiotech, Drug Discovery Today, European Life Sciences, Future Drugs, Going to Meet, Health Economics, Inpharm.com, Labroots, Medchem.com, Metabolomics.net, PharmaPhorum, PharmaVoice, Pharmcast, PMR, Report Buyer, SelectsScience.net, Technology Networks, Translational Biomedicine
SMi have had an established portfolio of Pharmaceutical, Defence, Energy, Finance and PPP/PFI events running since 1993. We are at the forefront of linking businesses with information, organising over 150 Conferences, Workshops and Masterclasses every year. All our events are research driven and highly targeted towards senior level professionals, designed to help you make informed decisions and remain at the cutting edge of business information.
SMi Conferences offer you an unrivalled opportunity to network within your area of business and our Workshops and Masterclasses provide an intimate, interactive forum in which to learn about the latest techniques and developments.
SMi Group Ltd,
Unit 122, Great Guildford Business Square,
30 Great Guildford Street,
London, SE1 0HS,
United Kingdom.
Tel: +44 (0) 20 7827 6000
Fax: +44 (0) 20 7827 6001
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biomarkers Summit here
News-ID: 154487 • Views: …
More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference
The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation.
Industry leaders will uncover the…

Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK.
With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading…

FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022.
With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and…
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week.
With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman.
The…
More Releases for Biomarker
Transformative Trends Impacting the Multiplex Biomarker Imaging Market Landscape …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Multiplex Biomarker Imaging Market Size By 2025?
In recent times, the size of the multiplex biomarker imaging market has experienced significant growth. There is an expected rise from $0.49 billion in 2024 to $0.54 billion in 2025, with a compound annual growth rate (CAGR) of…
Blood-Based Biomarker Market Beyond the Needle: The Future of Diagnostics Lies i …
Blood-Based Biomarker Market worth $51.71 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Blood-Based Biomarker Market - (By Type (Screening Biomarker, Diagnosis Biomarker, Others), By Disease (Cancer, Neurological Disorders, Others), By Application (Diagnostics, Drug Discovery, Personalized Medicine)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic,…
Biomarker Discovery Outsourcing Services Market Biomarker Discovery Outsourcing: …
Biomarker Discovery Outsourcing Services Market to reach over USD 52.82 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biomarker Discovery Outsourcing Services Market Size, Share & Trends Analysis Report By Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers And Surrogate Endpoints),
Therapeutic Area (Oncology, Neurology, Cardiology, Autoimmune Diseases), Discovery Phase (Biomarker Identification, Biomarker Validation,…
Biomarker and Companion Diagnostics Conference | Modeling Strategies for Biomark …
MarketsandMarkets presents the Immunobio Series, an extraordinary set of conferences taking place on 20-21 June 2024 in Boston, USA.
Register Now @ https://events.marketsandmarkets.com/2nd-annual-biomarker-and-companion-diagnostics-conference-usa-edition/register
MarketsandMarkets 5th Annual Biomarker and Companion Diagnostics Conference:
Immerse yourself in the realm of biomarkers at our flagship event, where industry leaders and experts converge to propel innovation in healthcare, diagnostics, and personalized medicine. This conference serves as a dynamic platform for collaboration, knowledge sharing, and exploration of cutting-edge…
Central Nervous System (CNS) Biomarkers Market Analysis Forecast 2023-2028 Globa …
The Central Nervous System (CNS) biomarkers market refers to the market for biomarkers used in the diagnosis, prognosis, and monitoring of diseases and disorders affecting the central nervous system. The central nervous system includes the brain and spinal cord, and disorders affecting this system can have significant impacts on an individual's health and well-being.
CNS biomarkers are measurable indicators that can provide information about the state of the central nervous system,…
Multiplex Biomarker Imaging Market - Advanced Solutions for Comprehensive Biomar …
Newark, New Castle, USA: The "Multiplex Biomarker Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Multiplex Biomarker Imaging Market: https://www.growthplusreports.com/report/multiplex-biomarker-imaging-market/8558
This latest report researches the industry structure,…